The tweet was deleted by the author.
But we saved everything 🙂.
NeoGenomics has announced the introduction of Paletrra, a groundbreaking spatial proteomics solution.
This innovation aims to convert every tissue into deep visual insights, enhancing decision-making and accelerating clinical advancements. Supported by over a decade of expertise in MultiOmyx™, a cyclic immunofluorescence technology, Paletrra promises to set a new standard in proteomics. This development underscores NeoGenomics' commitment to advancing precision medicine and providing comprehensive tools for researchers and clinicians.